Biological and clinical features in preclinical and (very) early spondyloarthritis

Biological and clinical features in preclinical and (very) early spondyloarthritis - Pre-SpA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54532

Enrollment

500

Registered

2012-07-19

Start date

2013-03-05

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bechterew Spondyloarthritis Bechterew, spondyloarthritis

Interventions

Not applicable.

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - First degree relative of an HLA-B27 positive Ankylosing Spondylitis (Bechterew) patient - Age at inclusion 18-40 years

Exclusion criteria

Exclusion criteria: - Established diagnosis of sponyloarthritis - Concomitant conditions that impact participation

Design outcomes

Primary

Measure	Time frame
Identify and validate biomarkers which can give more insight in the pathofysiology and (early) diagnosis of SpA	—

Secondary

Measure	Time frame
Create a biobank with biological samples and clinical data to find new biomarkers in SpA patients with future techniques.	—

Countries

Netherlands

Contacts

Public ContactM.G.H. Sande

Amsterdam UMC

kir@amsterdamumc.nl020-5667765

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)